Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Telomycin (CAS 19246-24-3)

0.0(0)
Write a reviewAsk a question

Application:
Telomycin is an antibiotic that potently inhibits gram-postive bacteria
CAS Number:
19246-24-3
Purity:
>95%
Molecular Weight:
1272.3
Molecular Formula:
C59H77N13O16
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Telomycin, designated by CAS number 19246-24-3, is a unique macrocyclic peptide antibiotic that has been isolated from the actinomycete Streptomyces canus. This compound is known for its distinct structure composed of multiple amino acid residues, including rare dehydroamino acids, which confer significant stability and specificity to its mechanism of action. Telomycin operates primarily by targeting the bacterial ribosome, where it binds to the peptidyl transferase center (PTC) of the 50S ribosomal subunit. This binding inhibits the peptidyl transferase activity, which is crucial for the formation of peptide bonds between amino acids during protein synthesis. By disrupting this fundamental process, telomycin effectively halts bacterial protein synthesis, leading to a cessation of bacterial growth. In research contexts, telomycin has been employed as a tool to study protein synthesis, particularly focusing on the role and function of the ribosomal PTC. Its ability to bind specifically to this site makes it a valuable probe for understanding the complex details of ribosomal structure and function, as well as the mechanism of action of ribosome-targeting antibiotics. Additionally, studies involving telomycin contribute to broader research on antibiotic resistance mechanisms, helping to explain how bacteria adapt to and circumvent the effects of ribosomal inhibitors.


Telomycin (CAS 19246-24-3) References

  1. Telomycin, a new antibiotic.  |  MISIEK, M., et al. Antibiot Annu. 5: 852-5. PMID: 13521903
  2. Microbiological studies on telomycin.  |  GOUREVITCH, A., et al. Antibiot Annu. 5: 856-62. PMID: 13521904
  3. Pharmacological studies with telomycin.  |  TISCH, DE., et al. Antibiot Annu. 5: 863-8. PMID: 13521905
  4. Occurrence of cis- and trans-3-hydroxy-L-proline in acid hydrolyzate of telomycin.  |  IRREVERRE, F., et al. 1962. Biochem Biophys Res Commun. 9: 69-71. PMID: 13956698
  5. Detection of Novel Proline 3-Hydroxylase Activities in Streptomyces and Bacillus spp. by Regio- and Stereospecific Hydroxylation of l-Proline.  |  Mori, H., et al. 1996. Appl Environ Microbiol. 62: 1903-7. PMID: 16535329
  6. Micromonospora schwarzwaldensis sp. nov., a producer of telomycin, isolated from soil.  |  Gurovic, MSV., et al. 2013. Int J Syst Evol Microbiol. 63: 3812-3817. PMID: 23667141
  7. Biosynthetic Studies of Telomycin Reveal New Lipopeptides with Enhanced Activity.  |  Fu, C., et al. 2015. J Am Chem Soc. 137: 7692-705. PMID: 26043159
  8. Structure and Antibacterial Activity of Ambobactin, a New Telomycin-Like Cyclic Depsipeptide Antibiotic Produced by Streptomyces ambofaciens F3.  |  Wei, S., et al. 2015. Molecules. 20: 16278-89. PMID: 26370952
  9. Proton magnetic resonance assignments of the polypeptide antibiotic telomycin.  |  Kumar, NG. and Urry, DW. 1973. Biochemistry. 12: 3811-7. PMID: 4745647
  10. Mode of action of the cyclic depsipeptide antibiotic LL-AO341 beta 1 and partial characterization of a Staphylococcus aureus mutant resistant to the antibiotic.  |  Oliva, B., et al. 1993. J Antimicrob Chemother. 32: 817-30. PMID: 7511579

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Telomycin, 500 µg

sc-202356
500 µg
$560.00